Citius Pharmaceuticals (CTXR) Q4 2024 Annual Earnings
CTXR·Reported February 14, 2025·Before market open
Diluted EPS came in at $-1.30, missed the $-1.25 consensus by $0.05.
Diluted EPS
$-1.30missed by $0.05
Consensus: $-1.25
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Citius Pharmaceuticals's Q4 2024 earnings report.
Citius Pharmaceuticals (CTXR) reported Q4 2024 earnings on February 14, 2025 before market open.
Citius Pharmaceuticals reported diluted EPS of $-1.30 for Q4 2024.
EPS missed the consensus estimate of $-1.25 by $0.05.
You can read the 10-K/A periodic report (0001213900-25-006997) directly on SEC EDGAR. The filing index links above go to sec.gov.